1)Klimstra DS, Kloppell G, La Rosa S, et al. Classification of neuroendocrine neoplasms of the digestive system. In WHO Classification of Tumours Editorial Board(ed). WHO Classification of Tumours:Digestive System Tumours, 5th ed. IARC, Lyon, p16, 2019
2)Brierly JD, Gospodarowicz MK, Wittekind C(eds). TNM Classification of Malignant Tumours, 8th ed. Wiley-Blackwell, 2017
3)Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma:a clinicopathologic study. Gastroenterology 104:994-1006, 1993
4)Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 95:74-87, 2012
5)日本神経内分泌腫瘍研究会(JNETS)膵・消化管神経内分泌腫瘍診療ガイドライン第2版作成委員会(編).膵・消化管神経内分泌腫瘍(NEN)診療ガイドライン,第2版.金原出版,2019
6)乗田一明,八田和久,小池智幸,他.術前に詳細な内視鏡観察を行ったType3胃神経内分泌腫瘍の1例.Gastroenterol Endos 59:177-183, 2017
7)Seya T, Shinji E, Tanaka N, et al. A case of multiple gastric carcinoids that could not be preoperatively diagnosed. J Nippon Med Sch 74:430-433, 2007
8)Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas:pathogenesis, pathology, and behavior. World J Surg 20:168-172, 1996
9)赤松泰次,海崎泰治,斎藤裕輔.Type III(sporadic type)胃カルチノイド腫瘍の多施設集計.胃と腸 48:1023-1028, 2013